Overview

Effects of Vardenafil on Clinical Symptoms and Peripheral Blood Flow in Patients With Raynaud's Syndrome

Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether vardenafil is effective in improving clinical symptoms and peripheral blood flow in patients with primary and secondary Raynaud phenomenon.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
University of Cologne
Treatments:
Phosphodiesterase 5 Inhibitors
Vardenafil Dihydrochloride